| Patent | Date |
|---|
Crystalline modifications of methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phenyl)amino](ph- enyl)methylidene}-2-oxo-2,3-dihydro-1H-indole-6-carboxylate salts and methods of preparation thereof
Grant 10,532,981 - Tieger , et al. Ja | 2020-01-14 |
Crystalline form of Canagliflozin and a method of its preparation
Grant 10,457,671 - Zezula , et al. Oc | 2019-10-29 |
Crystalline Modifications Of Methyl (3z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phenyl)amino](ph- Enyl)methylidene}-2-oxo-2,3-dihydro-1h-indole-6-carboxylate Salts And Methods Of Preparation Thereof
App 20190055197 - TIEGER; Eszter ; et al. | 2019-02-21 |
Crystalline Form Of Canagliflozin And A Method Of Its Preparation
App 20180327395 - ZEZULA; Josef ; et al. | 2018-11-15 |
Method for preparing methyl (Z)-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]ph- enylmethylene)oxindole-6-carboxylate (intedanib, nintedanib)
Grant 10,125,122 - Meca November 13, 2 | 2018-11-13 |
Method For Preparing Methyl (z)-3-[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phehyl]amino]phe- Nylmethylene)-oxindole-6-carboxylate (intedanib, Nintedanib)
App 20180215735 - MECA; Ludek | 2018-08-02 |
Method of preparing vortioxetine
Grant 9,920,021 - Klvana , et al. March 20, 2 | 2018-03-20 |
Stable polymorph of the salt of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-.alpha.]- pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-anime with L-tartaric acid
Grant 9,862,723 - Richter , et al. January 9, 2 | 2018-01-09 |
Method Of Preparing Vortioxetine
App 20170204074 - KLVANA; Robert ; et al. | 2017-07-20 |
Pharmaceutically acceptable cocrystals of N-[2-(7-methoxyl-1-naphtyl)ethyl]acetamide and methods of their preparation
Grant 8,927,771 - Miller , et al. January 6, 2 | 2015-01-06 |
Salts of desvenlafaxine and a method of their preparation
Grant 8,779,005 - Ridvan , et al. July 15, 2 | 2014-07-15 |
Grafted macromolecular conjugates of doxorubicin with anticancer activity and method of their preparation
Grant 8,603,990 - Etrych , et al. December 10, 2 | 2013-12-10 |
Method for the preparation of dabigatran
Grant 8,394,961 - Jirman , et al. March 12, 2 | 2013-03-12 |
Method for the preparation of dabigatran and its intermediates
Grant 8,394,962 - Lustig , et al. March 12, 2 | 2013-03-12 |
Method for the preparation of (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine)
Grant 8,207,356 - Ridvan , et al. June 26, 2 | 2012-06-26 |
Method for the preparation of zolmitriptan
Grant 8,143,417 - Voslar , et al. March 27, 2 | 2012-03-27 |
Method for the preparation of (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine)
Grant 8,071,791 - Ridvan , et al. December 6, 2 | 2011-12-06 |
Salts of bazedoxifene
Grant 8,034,807 - Jirman , et al. October 11, 2 | 2011-10-11 |
Process for the preparation of solifenacin
Grant 8,034,942 - Jirman , et al. October 11, 2 | 2011-10-11 |
PH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy
Grant 7,919,076 - Ulbrich , et al. April 5, 2 | 2011-04-05 |
Specific Impurities Of Montelukast
App 20110034692 - Halama; Ales ; et al. | 2011-02-10 |
Method of racemization of the R(-) isomer of the (2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid methyl ester
Grant 7,754,883 - Hajicek , et al. July 13, 2 | 2010-07-13 |
Method for manufacturing crystalline form I of clopidogrel hydrogen sulphate
Grant 7,714,133 - Veverka , et al. May 11, 2 | 2010-05-11 |
Method of manufacturing (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine)
Grant 7,709,662 - Ridvan , et al. May 4, 2 | 2010-05-04 |
Method of preparation of (R)-(-)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide
Grant 7,638,649 - Hajicek , et al. December 29, 2 | 2009-12-29 |
| 